Neuphoria Therapeutics Inc. (NEUP) Total liabilities 2025–2026
Neuphoria Therapeutics Inc. (NEUP) total liabilities at each fiscal year-end, per SEC filings.
$4.1MFY2026 · since FY2025: $9.6M → $4.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $4.1M | -57.1% |
| FY2025 | $9.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice